North Carolina Physicians' Group Calls for Halt to Atrium COVID Vaccine Trial for Children
May 19, 2022 20:00 ET
|
NC Physicians For Freedom
WINSTON-SALEM, N.C., May 19, 2022 (GLOBE NEWSWIRE) -- The North Carolina Physicians for Freedom (NCPFF), a large network of physicians and other health care professionals, called for the cessation...
First Patient Dosed in AstraZeneca’s Phase III COVID-19 Vaccine Trial at Headlands’ JEM Research Institute Site in Florida
September 01, 2020 09:00 ET
|
Headlands Research
SAN FRANCISCO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Headlands Research is pleased to announce that on Friday, Aug. 28, its JEM Research Institute clinical trial site in Lake Worth, Florida,...
Multiple Headlands Research Sites Selected for AstraZeneca’s Phase III COVID-19 Vaccine Trial
August 11, 2020 09:00 ET
|
Headlands Research
SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in AstraZeneca’s upcoming Phase III COVID-19 vaccine...
Headlands Research Sites Chosen for Crucial COVID-19 Vaccine Trials
July 16, 2020 13:28 ET
|
Headlands Research
SAN FRANCISCO, July 16, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in numerous upcoming COVID-19 vaccine clinical trials....
INC Research Bolsters Support for Vaccine Trials through Expanded Site and Patient Initiatives
April 06, 2017 14:52 ET
|
INC Research, LLC
RALEIGH, N.C., April 06, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, will demonstrate its continued commitment...
INC Research Extends Catalyst Program with Launch of Vaccine Catalyst Site Network
July 27, 2016 09:52 ET
|
INC Research, LLC
RALEIGH, N.C., July 27, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced the launch of the...